Mostrar el registro sencillo del ítem

dc.contributor.author
Virgolini, Miriam Beatriz  
dc.contributor.author
Michael, Aschner  
dc.contributor.other
Slikker, William  
dc.contributor.other
Michael, Aschner  
dc.contributor.other
Costa, Lucio G.  
dc.date.available
2023-02-28T18:29:35Z  
dc.date.issued
2021  
dc.identifier.citation
Virgolini, Miriam Beatriz; Michael, Aschner; Molecular mechanisms of lead neurotoxicity; Elsevier; 6; 2021; 159-214  
dc.identifier.isbn
978-0-12-823775-5  
dc.identifier.uri
http://hdl.handle.net/11336/189149  
dc.description.abstract
Lead (Pb2+) is a non-essential metal with numerous industrial applications that have led to its ubiquity in the environment. Thus, not only occupational-exposed individuals? health is compromised, but also that of the general population and in particular children. Notably, although the central nervous system is particularly susceptible to Pb2+, other systems are affected as well. The present study focuses on molecular mechanisms that underlie the effects that arise from the presence of Pb2+ in situ in the brain, and the possible toxic effects that follows. As the brain barriers represent the first target of systemic Pb2+, mechanisms of Pb2+ entry into the brain are discussed, followed by a detailed discussion on neurotoxic mechanisms, with special emphasis on theories of ion mimicry, mitochondrial dysfunction, redox imbalance, and neuroinflammation. Most importantly, the confluence and crosstalk between these events is combined into a cogent mechanism of toxicity, by intertwining recent and old evidences from humans, in vitro cell culture and experimental animals. Finally, pharmacological interventions, including chelators, antioxidants substances, anti-inflammatory drugs, or their combination are reviewed as integrated approaches to ameliorate Pb2+ harmful effects in both developing or adult organisms.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
lead exposure  
dc.subject
mechanisms of toxicity  
dc.subject
neurotoxicity  
dc.subject
metals  
dc.subject.classification
Toxicología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Molecular mechanisms of lead neurotoxicity  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.type
info:eu-repo/semantics/bookPart  
dc.type
info:ar-repo/semantics/parte de libro  
dc.date.updated
2022-09-19T12:46:06Z  
dc.journal.volume
6  
dc.journal.pagination
159-214  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Cambridge, MA  
dc.description.fil
Fil: Virgolini, Miriam Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Farmacología Experimental de Córdoba. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Instituto de Farmacología Experimental de Córdoba; Argentina  
dc.description.fil
Fil: Michael, Aschner. Albert Einstein College of Medicine; Estados Unidos. Sechenov University; Rusia  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1016/bs.ant.2020.11.002  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S2468748020300138  
dc.conicet.paginas
364  
dc.source.titulo
Neurotoxicity of Metals: old issues and new developments?